Product

HB-302/HB-301

Aliases

HB-302/HB-301 Alternating 2-Vector Therapy

1 clinical trial

1 indication

Indication

Prostate Cancer

Clinical trial

A Phase 1/2 Study of Replicating Arenavirus-based Vector(s) Encoding Prostate Cancer-Associated Antigens in Participants With Metastatic Castration-Resistant Prostate Cancer

Status: Recruiting, Estimated PCD: 2024-09-01